SC 13G/A

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Company: Aclaris Therapeutics, Inc.
Filed: February 14, 2023
Accession Number: 0000921895-23-000520

View Document ↗ View on SEC.gov ↗